Solaraze
Solaraze is a prescription topical gel containing 3% diclofenac sodium, a nonsteroidal anti-inflammatory drug (NSAID). It is used to treat actinic keratoses, which are rough, scaly, precancerous patches of skin caused by chronic sun exposure.
Dosage by Body Weight
Apply to affected skin areas twice daily. Gently smooth the gel onto the lesions. The typical duration of therapy is 60 to 90 days. Avoid applying to open wounds, infected skin, or exfoliative dermatitis.
- Body Weight
- Below 5 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Solaraze in pediatric patients have not been established.
- Body Weight
- 5-7 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Solaraze in pediatric patients have not been established.
- Body Weight
- 8-10 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Solaraze in pediatric patients have not been established.
- Body Weight
- 11-15 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Solaraze in pediatric patients have not been established.
- Body Weight
- 16-20 kg
- Dose
- Not recommended
- Frequency
- Do not use
- Tracking Notes
- Safety and effectiveness of Solaraze in pediatric patients have not been established.
| Body Weight | Dose | Frequency | Tracking Notes |
|---|---|---|---|
| Below 5 kg | Not recommended | Do not use | Safety and effectiveness of Solaraze in pediatric patients have not been established. |
| 5-7 kg | Not recommended | Do not use | Safety and effectiveness of Solaraze in pediatric patients have not been established. |
| 8-10 kg | Not recommended | Do not use | Safety and effectiveness of Solaraze in pediatric patients have not been established. |
| 11-15 kg | Not recommended | Do not use | Safety and effectiveness of Solaraze in pediatric patients have not been established. |
| 16-20 kg | Not recommended | Do not use | Safety and effectiveness of Solaraze in pediatric patients have not been established. |
Formulation
Purpose
Treatment of actinic keratosis (AK) in adults
Generic Name
Diclofenac sodium 3%Scheduled Drug
No. This medicine is generally not treated as a scheduled/prescription-only drug in common consumer references, but local rules may vary.